Drawing for MNEMO JETS

USPTO serial 79345490

MNEMO JETS

Reviewed by CopyMark Law Group

Reg. 7220558Status 700Registered
Filing date
Status date
Registration date
Nov 21, 2023
Examiner
HERR, JENNA FRANCES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MNEMO JETS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jill Anderfuren

Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP550 West Adams StreetSuite 300Chicago, IL 60661

Goods and services

ClassDescriptionStatusFirst use
001biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutionsACTIVE—
005pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for the treatment of cancer and tumors; biological and pharmaceutical preparations for cancer and tumor treatment using immunotherapy; therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical products for medical use for the treatment of cancer and tumors; diagnostic preparations for medical purposes, namely, antigens, antibodies, cells for therapeutic useACTIVE—
040Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacture of therapeutic solutions, namely, antigens, antibodies, T cellsACTIVE—
042Scientific research services for medical purposes; scientific research and product development, namely, antigen identification, screening and development services; scientific and technological research services in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information with regard to immunotherapy; scientific research and development, namely, providing services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific research, namely, epigenetic antigen screening and identification services for therapeutic research purposes; medical research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; providing medical and scientific research information, namely, designing algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform for use in forecasting the characteristics of antigens and immunological responses through the use of algorithmsACTIVE—
044providing medical information with regard to immunotherapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 22, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 22, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 16, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 16, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 2, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Aug 2, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 2, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 2, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 7, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2023RFNPREFUSAL PROCESSED BY IB—
Jan 9, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 8, 2023RFRRREFUSAL PROCESSED BY MPU—
Oct 26, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 25, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2022DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance